Summary

SheVolve by Green Regimen is a once-daily women’s wellness supplement for adults navigating peri-menopause and menopause. Its formula includes SheVari4, a standardized shatavari extract, and magnesium bisglycinate. This guide explains the ingredient, what current research evaluated, how it differs from a finished supplement, and where to find product directions and safety information.

What is shatavari?

Shatavari is the common name for Asparagus racemosus, a botanical with a long history of traditional use in Ayurveda. Shatavari supplements are not all alike. Extract source, standardization, serving amount, other ingredients, quality controls, and product directions can vary widely between products.

What is SheVari4?

SheVari4 is a proprietary, standardized root extract from Asparagus racemosus, commonly known as shatavari. The supplied ingredient documentation identifies a minimum 5% Shatavarin IV standardization. Standardization gives buyers a way to distinguish a named extract from an unspecified shatavari powder or a formula that does not identify its botanical material clearly.

SheVolve includes SheVari4 shatavari as a formulation differentiator and pairs it with magnesium bisglycinate. The product is a once-daily capsule for adult women seeking daily perimenopause and menopause wellness support.

What did the published SheVari4 study evaluate?

A 2026 randomized, double-blind, placebo-controlled study evaluated 100 mg daily of a specific SheVari4 root extract for eight weeks in 60 healthy women ages 40 to 55 who were pre-, peri-, or post-menopausal. The researchers assessed self-reported menopausal measures and menopause-specific quality-of-life measures, and reported greater improvement in several measures for the study-ingredient group than for placebo.

This is useful ingredient context, but the study evaluated the specified SheVari4 ingredient, not the finished SheVolve formula. It supports describing SheVari4 as a studied, standardized ingredient, without treating the study as a promise of an individual result from SheVolve.

What should a buyer compare in a daily shatavari and magnesium formula?

Check whether the label identifies shatavari as a standardized extract, the magnesium form and disclosed amount, other ingredients, daily directions, and warnings. SheVolve identifies SheVari4 shatavari and 100 mg magnesium as magnesium bisglycinate in its once-daily formula. Review the SheVolve product page and label for the complete current directions and warnings.

How SheVolve is formulated

SheVolve is formulated as a simple once-daily capsule for adult women seeking daily wellness support during peri-menopause and menopause. Green Regimen’s current product information states that SheVolve contains SheVari4 shatavari extract and magnesium bisglycinate, with no fillers, and is gluten-free, non-GMO, third-party tested, and made in a cGMP-compliant facility.

For complete ingredient facts, serving directions, warnings, and the most current product information, review the SheVolve product page and label before use.

Directions and important considerations

Green Regimen’s current directions are for adults to take one capsule daily with food, or as directed by a healthcare professional. Consistent use for at least 30 days is recommended on the current product information page.

SheVolve is not intended for pregnant or nursing individuals. Anyone with a medical condition or who takes medication should consult a physician before use. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.

Sources and fact-check notes

• Green Regimen, “Peri/Menopause Support Supplement | SheVolve by Green Regimen,” accessed August 22, 2026. Supports product identity, current formulation description, directions, warnings, and product attributes.
• Swaroop A. and Swaroop A., “Asparagus racemosus Root Extract (SheVari4) Alleviates Menopausal Symptoms in Pre-, Peri-, and Post-menopausal Healthy Women,” Cureus, 2026, doi: 10.7759/cureus.106987. Supports description of the ingredient study only. The paper’s authors are affiliated with the ingredient supplier and the study involved a specific extract and study population; do not characterize it as a trial of SheVolve.